Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Christofferson, Robb & Company (CRC) is an independent investment management firm specializing in the global private credit markets. Established in 2002, the firm is widely recognized as a pioneer in Significant Risk Transfer (SRT) transactions, where it partners with commercial banks to provide regulatory capital relief. CRC manages capital for institutional investors, including pension funds and endowments, through various credit-focused strategies. Headquartered in New York with a significant presence in London, the firm operates as an SEC-registered investment adviser. It is important to note that CRC is a financial services entity and does not operate within the life sciences, biotechnology, or healthcare sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Christofferson, Robb & Co.